Articles

Gilead’s twice-yearly injection for HIV prevention cut infections by 96% in a late-stage trial, the company said Thursday, building the case for regulatory approval of the treatment.

Bernstein continues to like Nvidia and Broadcom shares as top semiconductor picks, even as the sector has shed most of its year-to-date outperformance relative to the S&P 500.

Nothing is perfect, but the current index is a good compromise

Prices are no longer rising very rapidly

Signet Jewelers’ stock surged Thursday, after the diamond seller beat quarterly profit expectations, and indicated it was on course to break a long streak of same-store sales declines as marriage proposals are rising.

Labor market has cooled and hiring has slowed

Kroger’s CEO says the company is still committed to closing its merger with Albertsons, despite regulatory pushback.

An often-overlooked corner of the stock market is poised for big gains after the Federal Reserve cuts interest rates, according to a team of stock-market strategists at Goldman Sachs.

Mastercard boosting use of artificial intelligence to spot potentially compromised credit cards.

You may think financial advisers only want wealthy clients. But some take hardship cases—and even work pro bono.

The private Polaris Dawn space mission made history by completing the first commercial spacewalk early Thursday.

Financial autonomy and individual freedoms must be protected.